NATH BIOGENES (INDIA)
Back to All Ratios
|
NATH BIOGENES (INDIA) Last 5 Year Profit After Tax (PAT) Margin History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| PAT Margin (%) | 10.58 | 11.91 | 11.62 | -24.21 | 8.53 |
What is the latest Profit After Tax (PAT) Margin ratio of NATH BIOGENES (INDIA) ?
| Year | Profit After Tax (PAT) Margin |
|---|---|
| Mar2025 | 10.58 |
| Mar2024 | 11.91 |
| Mar2023 | 11.62 |
| Mar2022 | -24.21 |
| Mar2013 | 8.53 |
How is Profit After Tax (PAT) Margin of NATH BIOGENES (INDIA) Trending?
| Years | Profit After Tax (PAT) Margin | % Change | |
|---|---|---|---|
| Mar2025 | 10.58 | -11.17 | |
| Mar2024 | 11.91 | 2.50 | |
| Mar2023 | 11.62 | Positive | |
| Mar2022 | -24.21 | Negative | |
| Mar2013 | 8.53 | - | |
Other Financial Ratios of NATH BIOGENES (INDIA)
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Profit After Tax (PAT) Margin ratio of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹317.0 Cr | -1% | -4.8% | -12.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,770.3 Cr | -5.4% | -4.2% | -31% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹5,503.0 Cr | 7.1% | 1.1% | 15.6% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,912.2 Cr | -0.2% | -7.4% | -23.1% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,229.5 Cr | -4.1% | -3.1% | -27.1% | Stock Analytics | |
| INDO US BIOTECH | ₹258.5 Cr | -0.8% | -0.3% | -48.8% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | -1% |
-4.8% |
-12.8% |
| SENSEX | 1.6% |
2.7% |
6.3% |
You may also like the below Video Courses